de KoningJ., Van BekkumD.W., DickeK.A., et al. (1969). Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency. Lancet., 1, 1223–1227.
2.
FischerA., GriscelliC., FriedrichW., et al. (1986) Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968–1985. Lancet, 2, 1080–1084.
3.
GancbergD., and Draghia-AkliR. (2014). Gene and cell therapy funding opportunities in horizon 2020: an overview for 2014–2015. Hum. Gene Ther., 25, 175–177.
4.
GancbergD., NorstedtI., and Draghia-AkliR. (2014). Introduction: gene and cell therapy projects of the seventh framework program. Hum. Gene Ther. Clin. Dev., 25, 51.
5.
GrahamF.L., and van der EbA.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52, 456–467.
6.
HoogerbruggeP.M., SuzukiK., SuzukiK., et al. (1988). Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science, 239, 1035–1038.
7.
MavilioF. (2012). Gene therapies need new development models. Nature, 490, 7.
8.
MeuwissenH.J., GattiR.A., TerasakiP.I., et al. (1969). Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow - crucial role of histocompatibility matching. N. Engl. J. Med., 281, 691–697.
9.
van BekkumD.W., and de VriesM.J. (1967). Radiation Chimaeras.Academic Press: New York and London.
